Table 3. Changes in mean scores, total, wellbeing, sadness and tension QUALID scores, between baseline and follow-up (follow-up – baseline) for various patient characteristics.

		QUALID total score	p-value	Wellbeing score	p-value	Sadness score	p-value	Tension score	p-value
Gender	Men (n = 26)	3.2 (8.0)	.455a	0.5 (2.8)	.660a	0.6 (2.9)	.922a	2.0 (4.6)	.087a
	Women (n = 117)	2.7 (7.3)		1.0 (3.0)		0.8 (3.3)		0.9 (3.8)
Age, years	<79 (n = 24)	2.2 (8.4)	.790b	1.5 (3.5)	.665b	0.4 (4.0)	.899b	0.3 (4.2)	.259b
	80–84 (n = 24)	3.7 (7.5)		1.1 (2.5)		0.8 (3.6)		1.8 (4.5)
	85–89 (n = 38)	2.3 (7.6)		0.9 (2.8)		1.1 (3.2)		0.4 (3.6)
	90+ (n = 57)	3.1 (6.9)		0.7 (3.0)		0.7 (2.8)		1.7 (3.6)
General medical health	Good (n = 25)	1.4 (6.7)	.116b	0.6 (2.7)	.653b	0.2 (3.7)	.239 b	0.6 (3.5)	.139b
	Fair (n = 81)	3.8 (7.5)		1.2 (2.9)		1.1 (3.0)		1.6 (4.2)
	Poor (n = 31)	0.7 (7.3)		0.7 (3.0)		−.1 (3.4)		0.1 (3.6)
	Very poor (n = 6)	5.5 (8.6)		0.5 (3.6)		2.5 (3.7)		2.5 (3.4)
Type of dementia	Alzheimer's disease (n = 63)	2.5 (8.2)	.831a	1.0 (3.2)	.948a	0.8 (3.9)	.770a	0.7 (3.8)	.251a
	Other dementia (n = 80)	3.1 (6.8)		0.9 (2.7)		0.7 (2.7)		1.5 (4.1)
CDR score	1 (n = 40)	3.6 (6.4)	.493b	0.7 (2.9)	.845b	0.7 (2.4)	.810 b	2.2 (3.9)	.033b
	2 (n = 57)	3.3 (7.6)		1.2 (2.8)		0.6 (3.5)		1.4 (3.8)
	3 (n = 46)	1.6 (8.0)		0.8 (3.1)		0.9 (3.7)		−.2 (3.9)
PSMS score	6–13 (n = 41)	2.5 (6.1)	.566b	0.7 (2.4)	.603b	0.5 (3.1)	.921 b	1.3 (3.7)	.581b
	14–17 (n = 33)	4.4 (7.8)		1.8 (3.3)		0.7 (3.0)		1.9 (3.6)
	18–21 (n = 42)	2.4 (7.8)		0.9 (2.9)		0.9 (3.2)		0.6 (4.5)
	22–30 (n = 27)	2.1 (8.3)		0.4 (3.2)		0.9 (3.9)		0.7 (3.9)
NPI-Q-10 number of symptoms	0–1 symptoms (n = 56)	4.9 (6.4)	.042b	1.3 (3.1)	.384b	1.7 (2.5)	.009b	1.6 (3.2)	.376b
	2–3 symptoms (n = 48)	1.9 (7.7)		0.5 (2.7)		0.6 (3.3)		0.8 (4.5)
	4–9 symptoms (n = 39)	1.1 (7.8)		0.9 (2.9)		−.4 (3.7)		0.5 (4.1)
Number of psychotropic drugs on daily basis	0–2 (n = 136)	2.7 (7.4)	.543a	0.9 (2.9)	.992a	0.7 (3.3)	.415a	1.1 (4.0)	.295a
	3–9 (n = 7)	4.5 (7.1)		0.7 (3.0)		2.3 (3.3)		2.6 (2.9)
Sedatives	No (n = 122)	2.7 (7.6)	.607a	0.9 (3.0)	.947a	0.7 (3.2)	.720a	1.1 (4.1)	.538a
	Yes (n = 21)	3.7 (6.4)		1.0 (2.4)		1.1 (3.6)		1.6 (3.2)
Antipsychotics	No (n = 117)	2.9 (7.5)	.894a	0.9 (3.0)	.943a	0.7 (3.3)	.842a	1.2 (3.8)	.996a
	Yes (n = 26)	2.6 (7.3)		0.9 (2.9)		0.8 (3.2)		0.8 (4.5)
Anxiolytics	No (n = 119)	3.5 (7.6)	.022a	1.0 (3.0)	.508a	1.0 (3.3)	.060a	1.5 (4.0)	.019a
	Yes (n = 24)	−.33 (5.8)		0.6 (2.5)		−.3 (3.1)		−.5 (3.6)
Antidepressants	No (n = 93)	2.5 (6.8)	.349a	0.8 (2.8)	.667a	0.8 (3.2)	.918a	1.0 (3.8)	.346a
	Yes (n = 50)	3.4 (8.5)		1.2 (3.1)		0.7 (3.4)		1.4 (4.3)
Antidementia	No (n = 131)	2.8 (7.5)	.991a	1.0 (3.0)	.152a	0.7 (3.2)	.358a	1.1 (4.0)	.869a
	Yes (n = 12)	2.9 (6.3)		0.0 (1.7)		1.6 (3.6)		1.3 (3.2)
Type of ward	RU (n = 88)	2.6 (7.4)	.484a	0.8 (3.0)	.423a	0.5 (3.0)	.189a	1.3 (4.1)	.876a
	SCU (n = 55)	3.1 (7.4)		1.1 (2.7)		1.1 (3.7)		0.9 (3.8)
Time in ward	< = 6 months (n = 24)	3.4 (6.9)	.957a	0.6 (2.3)	.532a	1.3 (3.4)	.671a	1.6 (3.3)	.837a
	>6 months (n = 119)	2.7 (7.5)		1.0 (3.0)		0.6 (3.2)		1.1 (4.1)

^aMann-Whitney U-test, ^bKruskal-Wallis test, (N = 143).